Vivos Therapeutics Inc (NAS:VVOS)

Q1 2025 Vivos Therapeutics Inc Earnings Call Transcript

May 15, 2025 / 09:00 PM GMT

Release Date Price: $3.06 (+0.66%)

Transcript 8-K10-Q

Key Points

Positve

Vivos Therapeutics Inc (VVOS) has seen an 87% increase in total arches shipped, indicating strong product demand.
The company is expecting the acquisition of Sleep Center of Nevada (SCN) to be accretive to revenue and gross profit in the near term.
Vivos Therapeutics Inc (VVOS) has secured a non-binding term sheet for a $7.5 million senior loan to support the SCN acquisition and working capital.
The company has successfully transitioned to a new business model focusing on strategic alliances and acquisitions, which is expected to drive growth.
Vivos Therapeutics Inc (VVOS) has received FDA clearance for its appliances to treat severe obstructive sleep apnea (OSA), expanding its treatment capabilities.

Negative

First quarter 2025 total revenue decreased to $3 million from $3.4 million in the same period of 2024, primarily due to lower service revenue.
The company's gross margin decreased from 57% in Q1 2024 to 50% in Q1 2025, reflecting a decline in VIP service revenue.
Vivos Therapeutics Inc (VVOS) reported a net loss of $3.9 million for Q1 2025, slightly higher than the $3.8 million loss in Q1 2024.
Cash used in operations increased to $3.8 million in Q1 2025, up from $2.5 million in the prior year period.
The company's cash position decreased significantly from $6.3 million at the end of 2024 to $2.3 million as of March 31, 2025.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

VVOS.OQ - Vivos Therapeutics Inc
Q1 2025 Vivos Therapeutics Inc Earnings Call
May 15, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, everyone, and welcome to the Vivos Therapeutics, first quarter 2025 earnings call. At this time, participants are in a lesson only mode.

A question and answer session will follow management's remarks.

This conference call is being recorded and replay for today's call will be available on the investor relations section of Vivo's website.

And will remain posted there for the next 30 days.

I will now hand the call over to Brad Aman, Chief Financial Officer for introductions and the reading of the Safe Harbor statement. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
---------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.